The Freeman Hospital is an 800-bed tertiary referral centre in Newcastle upon Tyne, England. The hospital is managed by the Newcastle upon Tyne Hospitals NHS Foundation Trust and is a teaching hospital for Newcastle University.

There are 800 beds in Freeman Hospital.

During the past decade, Freeman Hospital conducted 133 clinical trials. In the 10-year time frame, 133 clinical trials started and 58 clinical trials were completed, i.e. on average, 43.6% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 41 clinical trials were completed. i.e. 75.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Freeman Hospital" #1 sponsor was "University College, London" with 13 trials, followed by "Boston Scientific Corporation" with 12 trials sponsored, "Hoffmann-La Roche" with 10 trials sponsored, "Bayer" with 7 trials sponsored and "Newcastle-upon-Tyne Hospitals NHS Trust" with 7 trials sponsored. Other sponsors include 186 different institutions and companies that sponsored additional 125 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Freeman Hospital" #1 collaborator was "Cancer Research UK" with 15 trials as a collaborator, "AstraZeneca" with 7 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 6 trials as a collaborator, "Newcastle-upon-Tyne Hospitals NHS Trust" with 4 trials as a collaborator and "University of Glasgow" with 4 trials as a collaborator. Other collaborators include 181 different institutions and companies that were collaborators in the rest 148 trials.

According to Clinical.Site data, the most researched conditions in "Freeman Hospital" are "Coronary Artery Disease" (12 trials), "Pulmonary Arterial Hypertension" (7 trials), "Atrial Fibrillation" (6 trials), "Heart Failure" (6 trials) and "Multiple Myeloma" (6 trials). Many other conditions were trialed in "Freeman Hospital" in a lesser frequency.

Most popular intervention types in "Freeman Hospital" are "Drug" (139 trials), "Device" (50 trials), "Other" (31 trials), "Procedure" (31 trials) and "Biological" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Dexamethasone" (8 trials), "Atezolizumab" (4 trials), "Bortezomib" (4 trials) and "Paclitaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Freeman Hospital" are 228 trials for "All" genders, 7 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are 73 active trials in "Freeman Hospital". 1 are not yet recruiting, 41 are recruiting, 30 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 125 completed trials in Freeman Hospital, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Freeman Hospital, 24 "Phase 1" clinical trials were conducted, 53 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 61 trials that are defined as “Not Applicable".